Catalyst Biosciences Inc. (NASDAQ:CBIO) Presents Encouraging Phase 2b Results For Subcutaneous...
Catalyst Biosciences Inc. (NASDAQ:CBIO) has announced safety and efficacy results from its Phase 2b study of subcutaneously administered Dalcinonacog Alfa (DalcA).
Catalyst presented DalcA study...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Altamira Therapeutics Ltd. (NASDAQ: CYTO) Announce Encouraging Bentrio Results in Influenza...
Altamira Therapeutics Ltd. (NASDAQ: CYTO) has announced positive results from Bentrio (AM-301) testing for therapeutics or prophylactic use in Influenza A virus treatment. Bentrio...
MAKE IT MODERN
LATEST REVIEWS
Unum Therapeutics Inc (NASDAQ:UMRX) Completes a Transaction Focused on the BOXR...
There are hundreds of inhibitors in the market today targeting mutant protein kinases. However, a majority of them do not have the required specificity....
MAKE IT MODERN
PERFORMANCE TRAINING
Portage Biotech (PRTG): Wild Ride Continues, But Uncertainty Looms
Portage Biotech (PRTG) has been on a rollercoaster lately, with shares closing up a dramatic 118% on August 27th, only to give...
Silvergate Capital Corp (NYSE:SI) Dramatic Surge: Exploring Potential Causes and Future Prospects Amid Industry...
Silvergate Capital Corp (NYSE: SI) experienced a significant increase of 52.21%, with its value rising from 1.7200 to 2.3100. The stock's prior...
Mustang Bio Inc (NASDAQ:MBIO) Says its MB-107 for the Treatment of X-linked Severe Combined...
It is in Mustang Bio Inc (NASDAQ:MBIO), where a culture of innovation thrives, thanks to a world-class team in-licenses and the development of next-generation...
Stocks to Watch Ahead of the “Twindemic” (APT, LAKE, ALST, DGX)
The pandemic is old news. Scientists and health policy experts are now worried about the rising potential for the “Twindemic” – a coincident crisis...
Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) Releases Encouraging Provisional Data From AROAAT2002 Study Evaluating ARO-AAT
Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) has announced positive provisional results of the 24-week liver biopsy AROAAT2002 open-label second phase clinical trial of ARO-ATT. ARO-ATT is...





















































